Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
JCO Precision Oncology|February 1, 2022
Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in NeuroblastomaAndrea Roderwieser, Frederik Sand, Esther Walter, et al.Molecular Cell|April 28, 2023
Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signalingEdoardo José Longarini, Helen Dauben, Carolina Locatelli, et al.Molecular Cell|May 21, 2021
Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human diseaseEvgeniia Prokhorova, Thomas Agnew, Anne R Wondisford, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2016
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine TumorsAatur D Singhi, Ta-Chiang Liu, Justin L Roncaioli, et al.Gastroenterology|February 28, 2018
Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival TimesSomak Roy, William A LaFramboise, Ta-Chiang Liu, et al.Nature Structural & Molecular Biology|October 13, 2020
Regulation of ALT-associated homology-directed repair by polyADP-ribosylationSong My Hoang, Nicole Kaminski, Ragini Bhargava, et al.Aging|March 31, 2010
Impact papers on aging in 2009Mikhail V Blagosklonny, Judy Campisi, David A Sinclair, et al.Science (New York, N.Y.)|December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastomaSandra Ackermann, Maria Cartolano, Barbara Hero, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Detection of Alternative Lengthening of Telomeres via Chromogenic In Situ Hybridization for the Prognostication of PanNETs and Other NeoplasmsChristopher M Heaphy, Simmi Patel, Katelyn Smith, et al.Nature|October 16, 2015
Telomerase activation by genomic rearrangements in high-risk neuroblastomaMartin Peifer, Falk Hertwig, Frederik Roels, et al.Pageof 11